Anika Therapeutics, Inc. (ANIK)
ANIK Stock Price Chart
Explore Anika Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze ANIK price movements and trends.
ANIK Company Profile
Discover essential business fundamentals and corporate details for Anika Therapeutics, Inc. (ANIK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
3 May 1993
Employees
288.00
CEO
Cheryl Renee Blanchard
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
ANIK Financial Timeline
Browse a chronological timeline of Anika Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 7 May 2026
Upcoming earnings on 30 Oct 2025
EPS estimate is $0.02, while revenue estimate is $27.53M.
Earnings released on 30 Jul 2025
EPS came in at -$0.13 matching the estimated -$0.13, while revenue for the quarter reached $28.22M , beating expectations by +2.49%.
Earnings released on 9 May 2025
EPS came in at -$0.06 falling short of the estimated $0.09 by -166.67%, while revenue for the quarter reached $26.17M , missing expectations by -6.76%.
Earnings released on 12 Mar 2025
EPS came in at -$0.03 falling short of the estimated -$0.01 by -200.00%, while revenue for the quarter reached -$1.29M , missing expectations by -104.59%.
Earnings released on 31 Oct 2024
EPS came in at -$0.25 falling short of the estimated $0.30 by -183.33%, while revenue for the quarter reached $38.75M , beating expectations by +33.63%.
Earnings released on 8 Aug 2024
EPS came in at $0.17 falling short of the estimated $0.23 by -26.09%, while revenue for the quarter reached $41.92M , missing expectations by -0.43%.
Earnings released on 8 May 2024
EPS came in at -$0.31 falling short of the estimated -$0.19 by -63.16%, while revenue for the quarter reached $40.52M , beating expectations by +3.35%.
Earnings released on 13 Mar 2024
EPS came in at -$4.30 falling short of the estimated -$0.26 by -1.55K%, while revenue for the quarter reached $42.97M , beating expectations by +3.79%.
Earnings released on 2 Nov 2023
EPS came in at -$0.45 falling short of the estimated -$0.33 by -36.36%, while revenue for the quarter reached $41.47M , beating expectations by +0.16%.
Earnings released on 8 Aug 2023
EPS came in at -$0.19 surpassing the estimated -$0.34 by +44.12%, while revenue for the quarter reached $44.30M , beating expectations by +9.23%.
Earnings released on 9 May 2023
EPS came in at -$0.71 falling short of the estimated -$0.36 by -97.22%, while revenue for the quarter reached $37.92M , beating expectations by +1.73%.
Earnings released on 6 Mar 2023
EPS came in at -$0.34 falling short of the estimated -$0.22 by -54.55%, while revenue for the quarter reached $39.62M , beating expectations by +5.08%.
Earnings released on 8 Nov 2022
EPS came in at -$0.29 falling short of the estimated -$0.24 by -20.83%, while revenue for the quarter reached $40.26M , beating expectations by +7.12%.
Earnings released on 3 Aug 2022
EPS came in at -$0.20 surpassing the estimated -$0.26 by +23.08%, while revenue for the quarter reached $39.66M , beating expectations by +4.77%.
Earnings released on 5 May 2022
EPS came in at -$0.20 surpassing the estimated -$0.31 by +35.48%, while revenue for the quarter reached $36.69M , beating expectations by +11.41%.
Earnings released on 8 Mar 2022
EPS came in at -$0.40 falling short of the estimated -$0.25 by -60.00%, while revenue for the quarter reached $35.82M , beating expectations by +11.76%.
Earnings released on 4 Nov 2021
EPS came in at $0.04 surpassing the estimated -$0.21 by +119.05%, while revenue for the quarter reached $39.54M , beating expectations by +7.87%.
Earnings released on 5 Aug 2021
EPS came in at $0.45 surpassing the estimated -$0.15 by +400.00%, while revenue for the quarter reached $38.15M , beating expectations by +7.74%.
Earnings released on 6 May 2021
EPS came in at $0.20 surpassing the estimated -$0.12 by +266.67%, while revenue for the quarter reached $34.29M , missing expectations by -69.70%.
Earnings released on 4 Mar 2021
EPS came in at -$1.10 falling short of the estimated -$0.10 by -1.00K%, while revenue for the quarter reached $32.69M .
Earnings released on 4 Nov 2020
EPS came in at -$0.45 falling short of the estimated -$0.08 by -462.50%, while revenue for the quarter reached $31.69M , beating expectations by +4.40K%.
ANIK Stock Performance
Access detailed ANIK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.